Valuation — not yet established
No valuation for Cidara Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($345.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Cidara Therapeutics
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2024 | PIPE | $105.0M | ▮ | ▮ |
| Apr 2024 | PIPE | $240.0M | ▮ | ▮ |
| Sep 2019 | Early Stage VC | $9.0M | ▮ | ▮ |
| Oct 2017 | Early Stage VC | $20.2M | ▮ | ▮ |
| Feb 2015 | Early Stage VC | $42.0M | ▮ | ▮ |
How Cidara Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Cidara Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Cidara Therapeutics raised?
- Cidara Therapeutics has raised $345.0M in total funding across 5 recorded rounds.
- When did Cidara Therapeutics last raise?
- Cidara Therapeutics last raised in Nov 2024 (PIPE), raising $105.0M.